STERIS plc (STE)

STERIS is a leading global provider of products and services supporting patient care with an emphasis on infection prevention, serving the healthcare, life sciences, and dental industries worldwide. The company operates through four reportable segments: Healthcare, Applied Sterilization Technologies (AST), Life Sciences, and Dental. The Healthcare segment offers a comprehensive suite of infection prevention consumables (cleaning chemistries, sterility assurance products), capital equipment (washers, sterilizers, surgical tables, lights, connectivity/OR integration solutions), and services (installation, maintenance, instrument and endoscope repair, outsourced sterile processing) to hospitals, ambulatory surgery centers, and endoscopy suites globally, competing with companies such as 3M, Baxter, Boston Scientific, Getinge, Olympus, and Stryker.

The AST segment acts as a third-party contract sterilization and testing service provider for medical device and pharmaceutical manufacturers, offering multiple sterilization modalities (including ethylene oxide and gamma/cobalt-60 irradiation) and validation services from facilities across the Americas, Europe, and Asia, competing primarily with Sterigenics and in-house manufacturer sterilization. The Life Sciences segment supports pharmaceutical and biopharma manufacturing, particularly vaccine and aseptic manufacturing customers, with consumable cleaning chemistries, barrier products, sterility assurance items, steam and vaporized hydrogen peroxide sterilizers, washer disinfectors, and related equipment maintenance services, competing with firms such as Belimed, Ecolab, Getinge, and Fedegari. The Dental segment provides instrumentation, infection control consumables, conscious sedation products, personal protective equipment, and water quality products to dental practitioners, dental schools, and related institutions, selling under STERIS brand names as well as private label, with three customers accounting for roughly 47% of segment revenue, and competes with companies including 3M, Dentsply/Sultan, Danaher/Sybron, and J&J/Ethicon.

Across all segments, the company's customer base spans hospitals, ambulatory surgery centers, medical device and pharmaceutical manufacturers, dental practices, government and educational institutions, and veterinary clinics in many countries, with no single customer accounting for more than 10% of revenue in the Healthcare, AST, or Life Sciences segments. STERIS relies on a global supply chain for raw materials such as stainless and carbon steel, chemicals, and plastics, along with specialized inputs like ethylene oxide and cobalt-60 for its AST operations, and it operates under extensive regulatory oversight from bodies such as the FDA, EPA, OSHA, and NRC in the U.S. as well as comparable authorities internationally. The company markets and distributes its products through a combination of direct sales, clinical specialists, corporate account managers, distributors, and dealers, supported by extensive customer training programs, and it maintains a substantial intellectual property portfolio of patents and trademarks to protect its technology and branding.